MEGAN HAMMER: Open Payments
NPI 1538743273 · MARSHFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,309 in 76 payments from 17 companies in 2025. Trend: 2023 $759 · 2024 $2,017 · 2025 $1,309
Food & beverage: $1,309
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 22 | $216 |
| Amgen Inc. | 13 | $181 |
| ABIOMED | 3 | $166 |
| Boston Scientific Corporation | 4 | $153 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $89 |
| Novo Nordisk Inc | 5 | $86 |
| AstraZeneca Pharmaceuticals LP | 5 | $75 |
| Merck Sharp & Dohme LLC | 4 | $64 |
| Kestra Medical Technology Services, Inc. | 2 | $56 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $49 |
Products named: LEQVIO, REPATHA, WATCHMAN FLX, LifeVest, VERQUVO, LOKELMA, Assure WCD, JARDIANCE.
Industry payments across MO — which companies pay providers there.
